These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 33289919)

  • 1. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.
    Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
    Cochrane Database Syst Rev; 2020 Dec; 12(12):MR000040. PubMed ID: 33289919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.
    Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
    BMJ; 2020 Dec; 371():m4234. PubMed ID: 33298430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial conflicts of interest in systematic reviews: associations with results, conclusions, and methodological quality.
    Hansen C; Lundh A; Rasmussen K; Hróbjartsson A
    Cochrane Database Syst Rev; 2019 Aug; 8(8):MR000047. PubMed ID: 31425611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Conflicts of Interest and Authors' Positions on Harms of Varenicline: a Cross-Sectional Analysis.
    Fabbri A; Nejstgaard CH; Grundy Q; Bero L; Dunn AG; Mohammad A; Mintzes B
    J Gen Intern Med; 2022 Feb; 37(2):290-297. PubMed ID: 34037923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
    Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
    JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review.
    Wang AT; McCoy CP; Murad MH; Montori VM
    BMJ; 2010 Mar; 340():c1344. PubMed ID: 20299696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias due to selective inclusion and reporting of outcomes and analyses in systematic reviews of randomised trials of healthcare interventions.
    Page MJ; McKenzie JE; Kirkham J; Dwan K; Kramer S; Green S; Forbes A
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):MR000035. PubMed ID: 25271098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Industry sponsorship and research outcome.
    Lundh A; Lexchin J; Mintzes B; Schroll JB; Bero L
    Cochrane Database Syst Rev; 2017 Feb; 2(2):MR000033. PubMed ID: 28207928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between Research Outcomes and Risk of Bias, Study Sponsorship, and Author Financial Conflicts of Interest in Reviews of the Effects of Artificially Sweetened Beverages on Weight Outcomes: A Systematic Review of Reviews.
    Mandrioli D; Kearns CE; Bero LA
    PLoS One; 2016; 11(9):e0162198. PubMed ID: 27606602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Industry sponsorship and research outcome.
    Lundh A; Sismondo S; Lexchin J; Busuioc OA; Bero L
    Cochrane Database Syst Rev; 2012 Dec; 12():MR000033. PubMed ID: 23235689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Revisiting financial conflicts of interest in FDA advisory committees.
    Pham-Kanter G
    Milbank Q; 2014 Sep; 92(3):446-70. PubMed ID: 25199895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of financial conflicts of interest in clinical practice guidelines: a case study analysis of guidelines from the Canadian Medical Association Infobase.
    Shnier A; Lexchin J; Romero M; Brown K
    BMC Health Serv Res; 2016 Aug; 16(a):383. PubMed ID: 27528247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
    Elder K; Turner KA; Cosgrove L; Lexchin J; Shnier A; Moore A; Straus S; Thombs BD
    CMAJ; 2020 Jun; 192(23):E617-E625. PubMed ID: 32538799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of financial conflicts of interest and quality of evidence in Japanese gastroenterology clinical practice guidelines.
    Murayama A; Kamamoto S; Murata N; Yamasaki R; Yamada K; Yamashita E; Saito H; Tanimoto T; Ozaki A
    J Gastroenterol Hepatol; 2023 Apr; 38(4):565-573. PubMed ID: 36518089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promotional tone in reviews of menopausal hormone therapy after the Women's Health Initiative: an analysis of published articles.
    Fugh-Berman A; McDonald CP; Bell AM; Bethards EC; Scialli AR
    PLoS Med; 2011 Mar; 8(3):e1000425. PubMed ID: 21423581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
    Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
    BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicts of interest and the quality of recommendations in clinical guidelines.
    Cosgrove L; Bursztajn HJ; Erlich DR; Wheeler EE; Shaughnessy AF
    J Eval Clin Pract; 2013 Aug; 19(4):674-81. PubMed ID: 23731207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.